ALBANY, New York, Feb. 18 (TNSjou) -- Albany Medical College issued the following news: * * * Researchers Awarded Ongoing Funding to Study Rare Genetic Disease By Cassie Nelson Two Albany Medical College research scientists have been awarded ongoing funding from the newly established Allman Institute for Personalized Medicine to study a rare but severe genetic disorder. Michael DiPersio, PhD, vice chair of research in the Department of Surgery and professor in the Department of Molecular an  more

NEW YORK, Feb. 18 [Category: BizHospital] -- NYU Langone Health, an academic medical center affiliated with New York University, posted the following news release: * * * Cancer Stress Protein Helps Tumors Hide from Immunity * A protein made by stressed cancer cells helps lung and pancreatic tumors evade the immune system, a new study shows. Led by NYU Langone Health researchers, the work found that new drugs designed to block the action of a protein called lipocalin 2 (LCN2) slowed cancer   more

NASHVILLE, Tennessee, Feb. 18 -- Vanderbilt University Medical Center issued the following news release: * * * Novel vaccine protects against C. diff disease and recurrence * A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine administered to the mucosal lining of the colon protected against illness, death, tissue damage and infection recurrence.  more

RARITAN, New Jersey, Feb. 19 -- Johnson and Johnson Innovative Medicine issued the following news release on Feb. 18, 2026: * * * RYBREVANT FASPRO(TM) (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO(TM) beyond lung cancer * Johnson & Johnson (NYSE:JNJ  more

LOS ANGELES, California, Feb. 19 (TNSjou) -- The UCLA Health issued the following news release: * * * UCLA researchers use CRISPR to "unlock" immune cells' power against solid tumors In a mouse study, researchers found they can use CRISPR to delete a gene called FLI1 to enhance human killer cell survival after tumor infiltration * A UCLA-led research team has identified a genetic "brake" that prevents the body's natural defense system from attacking solid tumors. By using CRISPR technology   more

RENO, Nevada, Feb. 19 -- The University of Nevada issued the following news: * * * Department of Energy awards $9 million for national research project on cactus pear's bioenergy potential University of Nevada, Reno researchers will lead the multistate five-year project Emma Lande As the quest to diversify and expand sustainable alternative energy products continues, the U.S. Department of Energy has awarded a $9 million grant to support research that will be led by researchers at the Univ  more

NASHVILLE, Tennessee, Feb. 18 (TNSjou) -- Vanderbilt University School of Medicine Basic Sciences issued the following news: * * * Study challenges traditional assumptions about gut inflammation and Crohn's disease Professor of Cell and Developmental Biology Ken Lau and his lab published new research that challenges a longstanding assumption about Crohn's disease: that all regions of the gut respond similarly to inflammation and treatment. The study, published in the Journal of Clinical Inves  more

NEW HAVEN, Connecticut, Feb. 18 (TNSjou) -- Yale University issued the following news: * * * Insights & Outcomes: Methanol, mitochondria, and new science at CERN Yale researchers find a new way to convert methane into methanol, discern patterns in the placement of mitochondria in the brain, and offer new guidelines for managing functional seizures. Meanwhile, a Yale astrophysicist is part of the Impact 100 list of influential Indian Americans. * This month's "Insights & Outcomes" clears a   more